469 related articles for article (PubMed ID: 18544649)
21. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
Chaussade C; Rewcastle GW; Kendall JD; Denny WA; Cho K; Grønning LM; Chong ML; Anagnostou SH; Jackson SP; Daniele N; Shepherd PR
Biochem J; 2007 Jun; 404(3):449-58. PubMed ID: 17362206
[TBL] [Abstract][Full Text] [Related]
22. Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies.
Roskoski R
Pharmacol Res; 2021 Jun; 168():105579. PubMed ID: 33774181
[TBL] [Abstract][Full Text] [Related]
23. Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.
Rathinaswamy MK; Burke JE
Adv Biol Regul; 2020 Jan; 75():100657. PubMed ID: 31611073
[TBL] [Abstract][Full Text] [Related]
24. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss.
Cizmecioglu O; Ni J; Xie S; Zhao JJ; Roberts TM
Elife; 2016 Oct; 5():. PubMed ID: 27700986
[TBL] [Abstract][Full Text] [Related]
25. PI3K
Jin JR; Gogvadze E; Xavier AR; Bohnacker T; Voelzmann J; Wymann MP
Front Immunol; 2020; 11():585070. PubMed ID: 33193405
[TBL] [Abstract][Full Text] [Related]
26. p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.
Saudemont A; Garçon F; Yadi H; Roche-Molina M; Kim N; Segonds-Pichon A; Martín-Fontecha A; Okkenhaug K; Colucci F
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5795-800. PubMed ID: 19297623
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.
Yip SC; El-Sibai M; Hill KM; Wu H; Fu Z; Condeelis JS; Backer JM
Cell Motil Cytoskeleton; 2004 Nov; 59(3):180-8. PubMed ID: 15468162
[TBL] [Abstract][Full Text] [Related]
28. Ligand-Biased Regulation of PtdIns(3,4,5)P3-Dependent Signal Transduction in GPCR Control of Pituitary Hormone Release.
Pemberton JG; Chang JP
Endocrinology; 2017 Feb; 158(2):378-401. PubMed ID: 27906555
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness.
Dbouk HA; Vadas O; Shymanets A; Burke JE; Salamon RS; Khalil BD; Barrett MO; Waldo GL; Surve C; Hsueh C; Perisic O; Harteneck C; Shepherd PR; Harden TK; Smrcka AV; Taussig R; Bresnick AR; Nürnberg B; Williams RL; Backer JM
Sci Signal; 2012 Dec; 5(253):ra89. PubMed ID: 23211529
[TBL] [Abstract][Full Text] [Related]
30. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
Wang P; Kumar P; Wang C; Defea KA
Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
[TBL] [Abstract][Full Text] [Related]
32. Critical roles of the p110 beta subtype of phosphoinositide 3-kinase in lipopolysaccharide-induced Akt activation and negative regulation of nitrite production in RAW 264.7 cells.
Tsukamoto K; Hazeki K; Hoshi M; Nigorikawa K; Inoue N; Sasaki T; Hazeki O
J Immunol; 2008 Feb; 180(4):2054-61. PubMed ID: 18250410
[TBL] [Abstract][Full Text] [Related]
33. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
Matheny RW; Lynch CM; Leandry LA
Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
[TBL] [Abstract][Full Text] [Related]
34. Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).
Vadas O; Dbouk HA; Shymanets A; Perisic O; Burke JE; Abi Saab WF; Khalil BD; Harteneck C; Bresnick AR; Nürnberg B; Backer JM; Williams RL
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18862-7. PubMed ID: 24190998
[TBL] [Abstract][Full Text] [Related]
35. PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control.
Walser R; Burke JE; Gogvadze E; Bohnacker T; Zhang X; Hess D; Küenzi P; Leitges M; Hirsch E; Williams RL; Laffargue M; Wymann MP
PLoS Biol; 2013; 11(6):e1001587. PubMed ID: 23824069
[TBL] [Abstract][Full Text] [Related]
36. Gβγ is a direct regulator of endogenous p101/p110γ and p84/p110γ PI3Kγ complexes in mouse neutrophils.
Rynkiewicz NK; Anderson KE; Suire S; Collins DM; Karanasios E; Vadas O; Williams R; Oxley D; Clark J; Stephens LR; Hawkins PT
Sci Signal; 2020 Nov; 13(656):. PubMed ID: 33144519
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.
Hohenester S; Gates A; Wimmer R; Beuers U; Anwer MS; Rust C; Webster CR
J Hepatol; 2010 Nov; 53(5):918-26. PubMed ID: 20675006
[TBL] [Abstract][Full Text] [Related]
38. Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.
Marqués M; Kumar A; Cortés I; Gonzalez-García A; Hernández C; Moreno-Ortiz MC; Carrera AC
Mol Cell Biol; 2008 Apr; 28(8):2803-14. PubMed ID: 18285463
[TBL] [Abstract][Full Text] [Related]
39. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
Dornan GL; Burke JE
Front Immunol; 2018; 9():575. PubMed ID: 29616047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
